Back to SC SCS Capital Management LLC
ALNY6 quarters
Position history for SCSCS Capital Management LLC's holdings in ALNYLAM PHARMACEUTICALS INC
Yes. SCS Capital Management holds 115,549 shares of ALNY (Alnylam Pharmaceuticals), worth $34.8M, as of its Q2 2026 13F filing. It reduced the position by 33,998 shares (-22.7%) from Q1 2026. SCS Capital Management has held ALNY since Q1 2025, across 6 quarterly 13F filings. ALNY is 0.3% of SCS Capital Management's reported 13F portfolio.
Current Value
$34.8M
Current Shares
115,549
Total Value Change
-$11.4M
Total Shares Change
-55,528
Quarter-by-Quarter History
Other major holders of ALNY: FMR LLC, Capital World Investors, VANGUARD GROUP INC